Davita-Laguna Hills Dialysis is a medicare approved dialysis facility center in Laguna Hills, California and it has 22 dialysis stations. It is located in Orange county at 25332 Cabot Road, Laguna Hills, CA, 92653. You can reach out to the office of Davita-Laguna Hills Dialysis at (949) 380-1925. This dialysis clinic is managed and/or owned by Davita. Davita-Laguna Hills Dialysis has the following ownership type - Profit. It was first certified by medicare in April, 2013. The medicare id for this facility is 552718 and it accepts patients under medicare ESRD program.
Name | Davita-Laguna Hills Dialysis |
---|---|
Location | 25332 Cabot Road, Laguna Hills, California |
No. of Dialysis Stations | 22 |
Medicare ID | 552718 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
25332 Cabot Road, Laguna Hills, California, 92653 | |
(949) 380-1925 | |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
NPI Number | 1801158498 |
Organization Name | Laguna Hills Dialysis |
Doing Business As | Nuevo Dialysis Llc |
Address | 25332 Cabot Rd Laguna Hills, California, 92653 |
Phone Number | (949) 460-9526 |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that nephrologists always communicated and cared for them. | 73% | 67% |
Patients who reported that nephrologists usually communicated and cared for them. | 13% | 15% |
Patients who reported that nephrologists sometimes or never communicated and cared for them. | 14% | 18% |
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 68% | 60% |
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 28% | 26% |
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 4% | 14% |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 72% | 62% |
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 17% | 20% |
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 11% | 18% |
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 78% | 62% |
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 18% | 26% |
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 4% | 12% |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 86% | 80% |
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 14% | 20% |
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 86% | 68% |
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 9% | 20% |
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 5% | 12% |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
Dialysis patients with Hemoglobin data | 29 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 17 |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 64 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 517 |
Percentage of adult patients getting regular hemodialysis at the center | 96 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita-Laguna Hills Dialysis with elevated calcium levels.
Patients with hypercalcemia | 77 |
Hypercalcemia patient months | 662 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
Patients with Serumphosphor | 81 |
Patients with Serumphosphor less than 3.5 mg/dL | 6 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 25 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
Patients with Serumphosphor greater than 7 mg/dL | 14 |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 68 |
Patient months included in arterial venous fistula and catheter summaries | 392 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 61 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 19 |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 50 |
Hospitalization Rate in facility | 181.5 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 326.2 |
Hospitalization Rate: Lower Confidence Limit | 105.2 |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita-Laguna Hills Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 16.3 (As Expected) |
Readmission Rate: Upper Confidence Limit | 27.6 |
Readmission Rate: Lower Confidence Limit | 8.2 |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita-Laguna Hills Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
Infection Rate in facility | .49 (As Expected) |
SIR: Upper Confidence Limit | 1.6 |
SIR: Lower Confidence Limit | .08 |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita-Laguna Hills Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 41 |
Transfusion Rate in facility | 41.2 (As Expected) |
Transfusion Rate: Upper Confidence Limit | 133.7 |
Transfusion Rate: Lower Confidence Limit | 14.7 |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita-Laguna Hills Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 243 |
Mortality Rate in facility | 20.2 (As Expected) |
Mortality Rate: Upper Confidence Limit | 28 |
Mortality Rate: Lower Confidence Limit | 14 |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago
Davita-Saddleback Dialysis Location: 23141 Plaza Pointe Drive, Laguna Hills, California, 92653 Phone: (949) 588-9211 |
Satellite Healthcare Laguna Hills Location: 25251 Paseo De Alicia, Suite 105, Laguna Hills, California, 92653 Phone: (949) 420-5700 |
Davita-Laguna Hills Dialysis Location: 25332 Cabot Road, Laguna Hills, California, 92653 Phone: (949) 380-1925 |
News Archive
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent - from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.
biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
› Verified 3 days ago